Stryker Hip Settlement News: Stryker Agrees to Settle Four NJ Lawsuits, Rottenstein Law Group LLP Reports

The firm actively files Stryker ABG II and Rejuvenate lawsuits on behalf of those who have suffered serious complications allegedly caused by the metal-on-metal hip devices recalled in 2012.

Print Email

New York, NY - December 19th, 2013 - Medical device manufacturer Stryker Corporation has agreed to settle four ABG II and Rejuvenate hip implant lawsuits in New Jersey, according to court documents. The Rottenstein Law Group LLP, a hip law firm that maintains the Stryker lawsuits and settlements informational website, notes that this Dec. 16 order follows October news that Stryker planned to set aside possibly $1 billion for ABG II and Rejuvenate-related litigation.

The parties settled the lawsuits for undisclosed sums, according to court documents (In re: Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation; MCL-296, Bergen County Superior Court, New Jersey).

Stryker announced in October that it will set aside between $700 million and more than $1 billion for metal-on-metal hip-related litigation, according to an Oct. 23 Wall Street Journal report.

“Settlements are one way for plaintiffs to be made whole again following complications with their metal-on-metal hip implants that cause injuries,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “With a settlement, there is a certain outcome for both sides, as opposed to going to trial, which is unpredictable.”

There are about 400 Stryker lawsuits pending in a consolidation of cases in U.S. District Court in Minnesota called a “multidistrict litigation” and more than 500 in a New Jersey consolidation called a “multicounty litigation.”

The Stryker lawsuits involve two of the company’s metal-on-metal hip implant products, the Rejuvenate and the ABG II, both recalled in July 2012. Claims against Stryker range from metal poisoning to device failure, according to court document. The U.S. Food and Drug Administration supports claimants’ allegations.

Stryker hip injury claims are part of a larger problem with metal-on-metal hip implants, Rottenstein said. DePuyOrthopaedics recently agreed to a multibillion-dollar settlement involving 8,000 ASR hip implant lawsuits in federal and state courts, she added.

“Of course, DePuy’s agreement is on a much larger scale, but there is always the possibility of Stryker taking a similar approach,” Rottenstein said.

The Rottenstein Law Group LLP encourages those who believe they have suffered from the Stryker implants’ alleged side effects to visit its FAQ page to learn more about Stryker hip lawsuits and side effects, and how to contact an attorney for a free consultation. For updates on lawsuit news, visit RLG's Stryker hip lawsuit Facebook page.

About The Rottenstein Law Group LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

For More Information, Please Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street, # 804
New York, NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)